Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: Retrospective survey involving 256 patients in Japan

Leukemia

Volumn 26, Issue 7, 2012, Pages 1482-1486

  Matsumura, T ^a   Kami, M ^a   Yamaguchi, T ^b   Yuji, K ^a   Kusumi, E ^a   Taniguchi, S ^a,c   Takahashi, S ^c   Okada, M ^d   Sakamaki, H ^e   Azuma, H ^f   Takanashi, M ^g   Kodo, H ^h   Kai, S ⁱ   Inoue Nagamura, T ^j   Kato, K ^j   Kato, S ^k  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f Hokkaido Cord Blood Bank   (Japan)

^g Metro Tokyo Red Cross Cord Blood Bank   (Japan)

^h Tokyo Cord Blood Bank   (Japan)

ⁱ Hyogo College of Medicine   (Japan)

^j Japan Cord Blood Bank Network   (Japan)

^k TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

adult acute lymphoblastic leukemia; cord blood transplantation; engraftment; graft versus host disease; graft versus leukemia effect

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; AGED; ALLOGENEIC CORD BLOOD TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BLEEDING; CANCER GRADING; CD34 SELECTION; CELL LINEAGE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS ANTIGENEMIA; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HAZARD RATIO; HEALTH SURVEY; HUMAN; HUMAN CELL; INTERSTITIAL PNEUMONIA; JAPAN; LEUKEMIA REMISSION; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOSIS; NEUTROPHIL ENGRAFTMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM GRADING; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84863783753     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.11     Document Type: Review

References (26)

1. Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 2006; 12: 1-30.
2. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827-1833.
3. Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM et al. Longterm outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant 2008; 41: 635-642.
4. Yanada M, Matsuo K, Suzuki T, Naoe T. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer 2006; 106: 2657-2663.
5. Ram R, Gafter-Gvili A, Vidal L, Paul M, Ben-Bassat I, Shpilberg O et al. Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis. Cancer 2010; 116: 3447-3457.
6. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
7. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
8. Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ et al. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. J Clin Oncol 2009; 27: 3634-3641.
9. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653-660.
10. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
11. Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009; 114: 4293-4299.
12. Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Kato S et al. Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL. Bone Marrow Transplant 2009; 43: 455-459.
13. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-1954.
14. Ferra C, Sanz J, de la Camara R, Sanz G, Bermudez A, Valcarcel D et al. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. Biol Blood Marrow Transplant 2010; 16: 957-966.
15. Narimatsu H, Miyakoshi S, Yamaguchi T, Kami M, Matsumura T, Yuji K et al. Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan. Blood 2008; 112: 2579-2582.
16. Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2009; 113: 1631-1638.
17. Yazaki M, Atsuta Y, Kato K, Kato S, Taniguchi S, Takahashi S et al. Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation. Biol Blood Marrow Transplant 2009; 15: 439-446.
18. Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010; 116: 2839-2846.
19. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
20. Bacigalupo A. Second EBMT Workshop on reduced intensity allogeneic hematopoietic stem cell transplants (RI-HSCT). Bone Marrow Transplant 2002; 29: 191-195.
21. Bacigalupo A. Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haematopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant 2004; 33: 691-696.
22. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695-706.
23. Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 2007; 109: 944-950.
24. Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S et al. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer 1999; 86: 1216-1230.
25. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
26. Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ. Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation. Blood 2009; 113: 2902-2905.